<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<STUDY_SET>
    <STUDY alias="DRP007995" center_name="TSUKUBA" accession="DRP007995">
        <IDENTIFIERS>
            <PRIMARY_ID label="BioProject ID">PRJDB11977</PRIMARY_ID>
        </IDENTIFIERS>
        <DESCRIPTOR>
            <STUDY_TITLE>Molecular characterization of aggressive malignant retroperitoneal solitary fibrous tumor: a case study</STUDY_TITLE>
            <STUDY_TYPE existing_study_type="Other"/>
            <STUDY_ABSTRACT>We performed target DNA sequencing using a comprehensive cancer panel for the primary differentiated tumor, primary dedifferentiated tumor, and lung/liver metastases. The gene mutations in TP53, FLT3, and AR were found in dedifferentiated tumors while the TP53 mutation (c.97del; p.Ser33fs) was especially found in all dedifferentiated tumors. The present study supports the idea that TP53 mutations promote malignancy in SFTs.</STUDY_ABSTRACT>
            <CENTER_PROJECT_NAME>Molecular characterization of aggressive malignant retroperitoneal solitary fibrous tumor: a case study</CENTER_PROJECT_NAME>
            <RELATED_STUDIES>
                <RELATED_STUDY>
                    <RELATED_LINK>
                        <DB>bioproject</DB>
                        <ID>PRJDB11977</ID>
                        <LABEL>PRJDB11977</LABEL>
                    </RELATED_LINK>
                    <IS_PRIMARY>true</IS_PRIMARY>
                </RELATED_STUDY>
            </RELATED_STUDIES>
            <STUDY_DESCRIPTION>We performed target DNA sequencing using a comprehensive cancer panel for the primary differentiated tumor, primary dedifferentiated tumor, and lung/liver metastases. The gene mutations in TP53, FLT3, and AR were found in dedifferentiated tumors while the TP53 mutation (c.97del; p.Ser33fs) was especially found in all dedifferentiated tumors. The present study supports the idea that TP53 mutations promote malignancy in SFTs.</STUDY_DESCRIPTION>
        </DESCRIPTOR>
    </STUDY>
</STUDY_SET>
